Hideki Tsuji - Profile and Investment Details

Investor Profile

Hideki Tsuji is a Venture Capital, University Program, Private Equity Firm based in Tokyo, Japan with a diverse investment portfolio that includes companies such as Vegetalia, Seven Dreamers Laboratories, EditForce, AI inside, TAGCyx Biotechnologies, Inc., ZenmuTech, Repertoire GenesisFressets, Nabiq, SWAT Mobility, Autonomous Control Systems Laboratory, Aidemy, OPALai, Ciespace, ReasonWhy, MONEY DESIGN, GORYO Chemical, Algal Bio, Nelumbo, Epigeneron, Mujin, Inc., Molcure, CREWT Medical Systems, Inc., Nohla Therapeutics, Locix, Metcela, Liquid, Adacotech, Quantum Biosystems, Tier IV, SEAOS, Phyzios, BionicM, Elixirgen Therapeutics, Tellus You Care, Routrek Networks, MiRTeL, Tricog Health, estie, VividQ, ImmunoScape, FLOSFIA, Wassha, Fyusion, SOCIUM, Startbahn, Green Earth Institute, Retrieva, Institution for a Global Society, BUGWORKS Research, Cyfuse Biomedical, C1X, Neural Pocket, Microwave Chemical, bitBiome, Japan Data Science Consortium, NS Materials, Peptidream, Prometech Software, 908 Devices, GlyTech, Agara, GLM, TXP Medical, PharmaBio, obniz, . Over time, Hideki Tsuji has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Hideki Tsuji is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Research and Development, Investment Management, Engineering, Portfolio Management, Startups, Science, Technology, Market Research, Innovation, Research, Consulting, UK Startups, Job Recruitment, B2B, Health Tech, Public Relations may find it worthwhile to explore potential connections with Hideki Tsuji, as their portfolio suggests a familiarity and interest in this area.

Understanding Hideki Tsuji’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.